Articles tagged with Vaccination
A study found that people exposed to vaccine content on social media were more likely to be misinformed about vaccines than those exposed to it on traditional media. Up to 20% of respondents were at least somewhat misinformed, with common claims including the link between vaccines and autism.
A recent study published in BMJ Case Reports highlights the serious complications of measles, including hepatitis, appendicitis, and viral meningitis. The authors report on three cases of adults treated for measles, highlighting the need for urgent efforts to ensure global coverage with two-dose measles vaccines.
A study found that HPV vaccination rates dropped significantly after the government's suspension of proactive recommendations, leading to potential 5,000 additional deaths. Restoring high-level political support and proactive recommendations could prevent most of this damage.
A new study found that the Zoster Vaccine Live shingles vaccination may prevent some older adults from having a stroke, reducing the risk by about 16% for ischemic stroke and 12% for hemorrhagic stroke. The vaccine's protection was strongest among people ages 66 to 79 years.
Rutgers researchers found young sexual minority men lack knowledge about HPV and its importance. Health care providers often inadequately discuss the virus and vaccine with these patients.
Recent advances in TB diagnostics, treatments and prevention offer hope for reducing and ultimately eliminating the burden of tuberculosis. The National Institute of Allergy and Infectious Diseases has made significant progress in improving TB diagnostics, therapeutic regimens and prevention approaches.
A single dose of the human papillomavirus (HPV) vaccine is as effective as multiple doses for preventing preinvasive cervical disease, which can later develop into cervical cancer. The risk of preinvasive cervical disease was lower in adolescents who received one, two, or three doses of the HPV vaccine compared to unvaccinated teens.
A phase 2 randomized trial study found that patients who received the Triplex vaccine had 50% fewer CMV complications and developed immunity against the virus. The vaccine showed promise as a potential therapy for transplant recipients with weakened immune systems.
A novel vaccine called Triplex reduced CMV complications by half and induced immunity in patients undergoing allogeneic hematopoietic stem cell transplant. No vaccine-associated safety concerns were identified in the phase 2 randomized clinical trial.
A new study found that peace of mind plays a significant role in parents' attitude towards vaccines, with reassurance from knowledge of benefits and healthcare providers influencing decisions. The research suggests that decision makers should consider these benefits when making funding decisions.
Researchers have identified a potential vaccine to prevent respiratory infections in humans by understanding how the human metapneumovirus (HMPV) hides from the immune system. A mutated form of HMPV was created, which triggers a stronger innate immune response, effectively preventing infection and promoting an adaptive immune response.
Researchers propose using genomic data and mathematical modelling to design vaccines for the specific geographic location where they will be used. This approach aims to minimize rates of pneumococcal disease, a serious infection that can cause pneumonia, sepsis, and bacterial meningitis.
A new study shows that a single dose of the Army-developed Zika vaccine can induce potent cross-neutralizing antibody responses against both Zika and dengue viruses. Researchers found that these antibodies, called MZ4, protected against both viruses in a mouse model of infection.
Researchers at Helmholtz Zentrum München developed a novel therapeutic approach to cure chronic hepatitis B infection. By knocking down the expression of the virus' proteins, they enabled successful vaccination with TherVacB, a novel therapeutic vaccine. The therapy aims to cure existing chronic diseases by activating immune cells.
A team of international scientists has created a global map of dengue transmission intensity and predicted that releasing infected mosquitoes with Wolbachia could reduce cases by up to 90%. The study also suggests that the Sanofi Pasteur dengue vaccine could reduce cases by up to 30%.
The study found good protection against meningococcal disease in vaccinated individuals, but no overall reduction in bacterial carriage. The findings highlight the importance of individual vaccination and identify high-risk behaviors associated with bacterial transmission.
Researchers Aarthi Narayanan and Remi Veneziano at George Mason University are developing a new vaccine design using DNA origami to deliver viral antigens. The customizability of the DNA structures enhances immunogenic potential while ensuring safety.
A new method to produce cheaper, longer-lasting vaccines has been developed using a protein called polyhedrin. Researchers found that PH(1-110) particles stored as dry powder can still generate antibodies after up to twelve months of storage.
A new analysis of HPV vaccine clinical trials raises doubts about their effectiveness, citing methodological problems and limited trial populations. The study found that the trials were not designed to detect cervical cancer, which takes decades to develop, and that vaccination may only prevent low-grade abnormal cell changes.
A study published in PLOS Neglected Tropical Diseases found that typhoid prevalence is likely higher than estimated due to missed blood cultures, with patients more likely to have cultures if older, feverish or suspected urinary tract infection.
Researchers developed a novel cryogel vaccine that primes the immune system to attack and eliminate acute myeloid leukemia cells in mice. The vaccine successfully protected against disease recurrence when combined with chemotherapy.
The International Vaccine Institute (IVI) has renewed its partnership with Sweden's Swedish International Cooperation Agency (Sida) to accelerate vaccine research and development for global health. The five-year partnership will focus on infectious diseases of global importance, including cholera, typhoid, and dengue.
The Partnership for Research on Ebola Vaccination (PREVAC) has received additional funding to evaluate three Ebola vaccine regimens for long-term safety and durability. The PREVAC-UP project will assess these factors over 5 years after vaccination, as well as the impact of co-infections like malaria and helminths on immune responses.
The AAFP has released updated Feline Retrovirus Testing and Management Guidelines, providing current information on pathogenesis, diagnosis, prevention, and treatment. The guidelines aim to optimize care for feline patients infected with FeLV and FIV, and offer practical guidance for veterinarians and cat caregivers.
The International Vaccine Institute (IVI) has received a $1.4 million grant from the Bill & Melinda Gates Foundation to develop international standards for oral cholera vaccine manufacturing. This will enable multiple manufacturers to produce low-cost vaccines, meeting global demand and ensuring uniform efficacy.
Researchers at Michigan Technological University have developed a single-particle method using atomic force microscopy to determine virus isoelectric points, improving the accuracy of characterization and paving the way for more efficient vaccine production and gene therapy manufacturing.
A recent Danish study found that vaccine misinformation resulted in a 50.4% drop in HPV vaccination rates, leaving around 26,000 girls unvaccinated and potentially exposing them to 180 avoidable cervical cancer cases and 45 deaths.
A pediatrician at Children's National Hospital wrote a 27-line poem inspired by her young patients' comments about vaccines. The poem, part of the 'Poetry and Medicine' series, aims to capture the optimism and resilience of children despite challenges. Dr. Sims hopes the poem will help build self-efficacy and resiliency in her patients.
Researchers found that intravenous BCG vaccination significantly increased protection against TB in rhesus macaques. The study showed that IV BCG elicited strong, sustained T cell responses in the lungs, leading to a high degree of protection against infection and disease.
A new study reveals that one dose of the HPV vaccine may prevent infection from the potential cancer-causing virus, with implications for reducing global cancer burden. The current two- or three-dose series may be replaced by a single dose regimen if ongoing clinical trials provide sustained benefits.
Researchers at Washington University School of Medicine found that T cells play a critical role in protecting against staph infections. The study suggests activating untapped immune cells and immunizing infants before birth to block toxin effects. This new approach shows promise for developing an effective staph vaccine.
A California law eliminating nonmedical exemptions increased vaccination rates and restored 'herd immunity,' preventing outbreaks. The study found a 3.3% increase in MMR coverage and a 4.3% increase in overall vaccination coverage, while nonmedical exemptions decreased by 2.4%.
A new study published in PLOS Medicine found that California's elimination of non-medical vaccine exemptions led to a significant increase in MMR vaccination coverage, with non-medical exemptions decreasing by 2.4% and medical exemptions increasing by 0.4%. The policy change was associated with a 3.3% increase in MMR coverage across th...
A new study found that a Zika vaccine developed by NIH improved fetal outcomes in pregnant monkeys and rhesus macaques infected with congenital Zika virus. The vaccine reduced virus levels and prevented fetal infection, suggesting sterilizing immunity may not be required for protection.
A research team developed a microneedle platform using fluorescent quantum dots to deliver vaccines and record vaccination history in the skin. The platform offers a dependable way for clinicians to keep accurate medical records, potentially saving millions of lives worldwide.
An experimental Zika DNA vaccine VRC5283 reduced virus levels and improved fetal outcomes in pregnant rhesus macaques. The results suggest the vaccine may prevent transmission to humans as well.
Researchers at the University of Adelaide have made significant progress in developing a novel Zika virus vaccine that prevents infection in pre-clinical models. The vaccine's effectiveness has been demonstrated in mouse models, offering a promising solution to prevent congenital effects in infants born to infected mothers.
Researchers developed a Zika vaccine that safely protects both mother and fetus from the virus. However, pregnancy weakens the immune response, requiring a higher dose of vaccination to be effective.
Researchers have successfully determined the three-dimensional structure of a vaccinia virus RNA polymerase at atomic resolution, providing key findings on virus multiplication. The complex is composed of various subunits and relies on host tRNA molecules to function, enabling an essential step in the pathogen's life cycle.
Researchers developed a vaccine that targets flagellin in the gut microbiota to reduce inflammation. The vaccine showed protection against intestinal inflammation and metabolic disorders such as diabetes and obesity.
A new species of insect virus, Binjari virus, has been identified that can be engineered to house genes from disease-causing flaviviruses. This non-infectious virus represents a flexible tool for testing diagnostics and vaccines for various infectious diseases, including yellow fever, dengue, and West Nile encephalitis.
A study in ferrets demonstrates a protective humoral immune response to a weakened form of SFTSV after a single inoculation, and no clinical disease or mortality. The findings suggest potential for this live-attenuated vaccine candidate to provide cross-genotype protection against the emerging virus.
A new study published in Annals of Internal Medicine found that extending the HPV vaccination age to include women and men up to 45 would produce small, but significant health benefits. The study used a health economic model to evaluate the added effectiveness and cost-effectiveness of such an extension.
A study found that almost 60% of eligible young travelers were not vaccinated due to clinician decision or guardian refusal, despite recommendations from the Advisory Committee on Immunization Practices. The researchers emphasize the urgent need for greater awareness of MMR vaccination benefits for international travelers.
Researchers have developed a novel vaccine that uses a virus-based platform to rewrite the body's natural response to peanut allergens, causing a non-allergic immune response. The vaccine has shown signs of success in mouse models and preliminary in vitro studies, paving the way for human trials.
A new field study in Nepal shows the typhoid vaccine is safe, immunogenic and effective against the disease, with results showing 7 cases out of 20,000 children vaccinated. The study's findings are significant, especially with the recent spread of drug-resistant typhoid, which threatens child health in affected regions.
Researchers developed a novel vaccine that protects against bovine tuberculosis (TB) without interfering with the tuberculin skin test. The new vaccine allows for simultaneous protection and accurate diagnosis of TB in cattle.
Researchers from Queen Mary University of London and Zhengzhou University have developed a personalised vaccine system that can delay the onset of pancreatic cancer. The system was tested in mice, where it doubled their survival time compared to those without the vaccine.
Researchers found that a plant-based compound called halofuginone improves the immune response to a potential dengue vaccine in mice, producing twice as many antibodies and binding more strongly. The compound mimics amino acid starvation, activating a pathway that results in better antibodies.
Researchers integrated human and animal treatment to eliminate roundworm infections and rabies in Tanzanian villages. The study found no difference in participation rates between combined and stand-alone events.
A phase I/II study of the Swedish vaccine candidate ETVAX found it to be safe and broadly immunogenic, inducing impressive immune responses in young children and infants. The vaccine showed high response rates among children aged 2-5 years and infants, with some even showing enhanced immune responses when given with an adjuvant.
A recent study by Drexel University researchers found that anti-vaccine messages on Instagram, which feature narratives, experience higher engagement than pro-vaccine posts. The team suggests that pro-vaccine posts could garner greater engagement if they provide information and evidence through a more narrative structure.
Outbreaks of vaccine-preventable diseases like measles and whooping cough were associated with introduction of legislation changing vaccine exemption laws in states. The study found a correlation between health improvements and increased legislative activity related to vaccine policies.
Researchers used fluorescent gel to test vaccine effectiveness in wild vampire bats, showing a 2.6-fold increase in population-level immunity compared to conventional non-spreadable vaccines. The study suggests a strategic switch from poisoning to vaccination could lead to a dramatic reduction in rabies across Latin America.
A study published in PLOS Pathogens found that mild Zika virus infection in fetuses can lead to abnormal brain development and impaired immunity in young animals. The research provides new insights into the potential outcomes of Zika virus infection and could point to new prevention and treatment strategies.
A new study finds that a vaccine against pneumococcal bacteria reduces the likelihood of severe pneumonia in children by 35%. The research also highlights the importance of vaccinating children to protect the whole community and reduce the spread of pneumococcus. By evaluating the effectiveness of pneumococcal vaccines in Asia, the stu...
A new study published in The American Journal of Pathology suggests that medroxyprogesterone acetate (MPA) is effective in preventing the development of cervical cancer in mice with precancerous lesions. MPA also decreased existing precancerous lesions, offering a non-invasive approach to combat cervical cancer.
Scientists developed an investigational vaccine that protected cynomolgus macaques against Ebola, Sudan, Marburg, and Lassa viruses, all causing severe disease and death. The quadrivalent VesiculoVax vaccine showed promising results in a study published in the Journal of Clinical Investigation.
The American College of Physicians (ACP) has released a new guidance statement for colorectal cancer screening in average-risk adults between 50 and 75 years old. The guidance suggests that physicians select the most suitable screening test for each patient based on factors such as benefits, harms, costs, availability, frequency, and p...
A team of University of Otago researchers is part of a major new vaccine research project to combat invasive non-typhoidal salmonellosis, a major killer of African children. The Vacc-iNTS project aims to develop an effective vaccine with a five-year budget of NZ$11.8 million.